The field of diabetes treatment is undergoing a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide are rapidly emerging as potential game-changers. These https://amienpjv193266.qodsblog.com/39164904/new-glp-1-receptor-agonists-retatrutide-and-trizepatide